製品名:4-(((Benzyloxy)carbonyl)amino)benzoic acid

IUPAC Name:4-{[(benzyloxy)carbonyl]amino}benzoic acid

CAS番号:5330-71-2
分子式:C15H13NO4
純度:95%
カタログ番号:CM322678
分子量:271.27

包装単位 有効在庫 価格(USD) 数量
CM322678-10g 3-4 Weeks ŵƛȐ
CM322678-25g 3-4 Weeks Ⱥŵƿ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:5330-71-2
分子式:C15H13NO4
融点:-
SMILESコード:O=C(O)C1=CC=C(NC(OCC2=CC=CC=C2)=O)C=C1
密度:
カタログ番号:CM322678
分子量:271.27
沸点:
MDL番号:MFCD00610465
保管方法:

Column Infos

Mitapivat
Jan. 03 2024, Agios announces Phase 3 ENERGIZE study of PYRUKYND (Mitapivat) met primary endpoint and both key secondary endpoints in adults with non-transfusion-dependent(NTD) alpha- or beta-thalassemia. The positive data showed Mitapivat’s potential to become the first oral therapy approved for NTD thalassemia.
Mitapivat is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency in the US, and for the treatment of PK deficiency in adult patients in the EU. By activating and stabilizing mutant pyruvate kinase, Mitapivat targets the underlying enzymatic defect that causes chronic hemolysis and ineffective erythropoiesis in order to restore enzyme activity.

Related Products